Modern Diagnostic & Research Centre IPO GMP & Review: Apply or Avoid?
Posted by : sachet | Mon Dec 29 2025
Modern Diagnostic & Research Centre IPO is open for bidding from 31st December 2025 to 2nd January 2026. It is a bookbuilding IPO of ₹36.89 crore, an entirely fresh issue of 0.41 crore shares. The issue will be listed on BSE and SME on its tentative listing date, 7th January 2026.
Modern Diagnostic & Research Centre IPO Details
The Modern Diagnostic & Research Centre IPO date is fixed between 31st December 2025 and 2nd January 2026. The face value of Modern Diagnostic & Research Centre shares stands at ₹10 per share, and the IPO Issue price band is set at ₹85 to ₹90 per share
MUFG Intime India Private Limited is the registrar of the Modern Diagnostic & Research Centre IPO and is responsible for managing the allotment process and initiating refunds. Check out the latest IPO details in the table below.
| IPO Allotment Date | 5th January 2026 |
| IPO Open Date | 31st December 2025 |
| IPO Close Date | 6th January 2026 |
| Refund Initiation | 1st January 2026 |
| Issue Size | 40,99,200 shares(agg. up to ₹37 Cr) |
| Face Value | ₹10 per share |
| Lot Size | 1,600 Shares |
| Issue Price | ₹85 to ₹90 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Listing Date | 7th January 2026 |
Modern Diagnostic & Research Centre IPO Share Reservation
Riddhi Display Equipment’s IPO is a bookbuilding IPO issue of 0.41 crore worth ₹36.89 crores. Modern Diagnostic & Research Centre IPO Limited shares will be listed on the BSE and the SME Exchange. Furthermore, SEBI has specified the share reservation criteria for different investor categories.
| Investor Categories | Shares Offered | Shares Percentage |
| Market Maker Shares Offered | 2,06,400 | 5.04% |
| QIB shares offered | 19,44,000 | 47.42% |
| NII (HNI) Shares Offered | 5,85,600 | 14.29% |
| Retail Shares Offered | 13,63,200 | 33.26% |
| Total Shares Offered | 40,99,200 | 100.00% |
Modern Diagnostic & Research Centre IPO GMP Grey Market Premium
GMP is the gap between the issue price band and the price at which company shares are currently trading in the grey market. Do you want to get live updates on the Modern Diagnostic & Research Centre IPO? If yes, then you’ve reached the right spot. Check the table below to learn about the GMP trends.
| GMP DATE | IPO Price | GMP Price | Estimated Listing Price | Estimated Gain |
| 2-1-2026 | – | – | – | – |
| 1-1-2026 | – | – | – | – |
| 31-12-2025 | ₹90.00 | ₹0.00 | ₹90.00 | 0.00% |
| 30-12-2025 | ₹90.00 | ₹0.00 | ₹90.00 | 0.00% |
| 29-12-2025 | ₹90.00 | ₹0.00 | ₹90.00 | 0.00% |
| 28-12-2025 | ₹90.00 | ₹0.00 | ₹90.00 | 0.00% |
| 27-12-2025 | ₹90.00 | ₹0.00 | ₹90.00 | 0.00% |
| 26-12-2025 | ₹90.00 | ₹0.00 | ₹90.00 | 0.00% |
| 25-12-2025 | ₹90.00 | ₹0.00 | ₹90.00 | 0.00% |
| 24-12-2025 | ₹90.00 | ₹0.00 | ₹90.00 | 0.00% |
| 23-12-2025 | ₹90.00 | ₹0.00 | ₹90.00 | 0.00% |
As of 31st December 2025, Modern Diagnostic & Research Centre IPO GMP stands at ₹0 per share, which means the share will likely show a listing at ₹90.00 on its tentative listing date, 7th January 2026.
GMP data is subject to change based on market trends and sentiments. You should check the live GMP status before applying for the Modern Diagnostic & Research Centre IPO GMP. Stay informed with Univest for real-time insights into IPOs and their GMP trends.
Modern Diagnostic & Research Centre IPO GMP Review
Check out the detailed Modern Diagnostic & Research Centre GMP IPO review for a thorough understanding of its potential to report listing gains on 7th January 2026. The Modern Diagnostic & Research Centre IPO review below will help you invest effectively to avoid significant losses. Explore more to make informed investment decisions on this IPO.
Financial Health
Assess a company’s financial performance to know about its ability to sustain a competitive edge. Thus, it is essential to understand the business’s economic growth and decline before applying for the Modern Diagnostic & Research Centre IPO.
Modern Diagnostic & Research Centre Limited’s revenue increased by 15% from ₹68.67 crores in March 2024 to ₹78.80 crores in March 2025. Moreover, the company’s PAT increased by 55% from ₹5.79 crores in March 2024 to ₹8.97 crores in March 2025.
Modern Diagnostic & Research Centre’s IPO has shown consistent revenue growth, indicating the company’s financial stability. Moreover, the brokers, investors, and RAs have a positive outlook for the Modern Diagnostic & Research Centre IPO for its tentative listing day, which is 7th January 2026.
Technical Analysis
Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technicals of the Modern Diagnostic & Research Centre IPO.
| Key Indicators | Value |
| PE Ratio (Price-to-Earnings) | 11.04 |
| EPS (Earnings Per Share) | 8.15 |
| RoNW | 43.27% |
| ROCE | 36.18% |
| ROE | 55.21% |
| EBITDA Margin | 23.04% |
| Price to Book Value | 4.78 |
| Market Capitalisation | ₹135.89 Cr |
The PE ratio of Modern Diagnostic & Research Centre Limited shares is 11.04, and its Earnings Per Share (EPS) stands at 8.15. Thus, the Modern Diagnostic & Research Centre IPO can deliver gains on its tentative listing date, 2nd January 2026.
Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Modern Diagnostic & Research Centre Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics.
| Indicators | Pre-IPO | Post-IPO |
| PE Ratio | 11.04 | 11.33 |
| EPS | 8.15 | 7.94 |
Modern Diagnostic & Research Centre IPO Subscription Status
The Modern Diagnostic & Research Centre IPO is to be opened for bidding on 31st December 2025. The subscription status for this IPO is yet to be announced. Stay informed on this passage to check the live Modern Diagnostic & Research Centre IPO Subscription Status.
| Investor Categories | Shares Offered | Shares Percentage | Shares Subscribed | Subscription to the Times |
| Market Maker Shares Offered | 2,06,400 | 5.04% | Yet to be announced | Yet to be announced |
| QIB shares offered | 19,44,000 | 47.42% | Yet to be announced | Yet to be announced |
| NII (HNI) Shares Offered | 5,85,600 | 14.29% | Yet to be announced | Yet to be announced |
| Retail Shares Offered | 13,63,200 | 33.26% | Yet to be announced | Yet to be announced |
| Total Shares Offered | 40,99,200 | 100.00% | Yet to be announced | Yet to be announced |
About Modern Diagnostic & Research Centre Limited
Modern Diagnostic & Research Centre was established in 1985. Modern Diagnostic & Research Centre Limited (MDRC) is a diagnostic chain in India, offering a comprehensive range of pathology and radiology services. The company provides reliable diagnostic tests, home specimen collection, online reports, and customised test packages for institutional customers and patients, tailored to their specific needs. The company operates 21 centres (18 labs, three diagnostic centres) across eight states, offering diagnostic services such as ultrasound, CT, MRI, X-ray, ECG, PFT, and specialised labs for heart and neuro care. The company has been providing services such as Pathology, Radiology and Home sample collection.
Modern Diagnostic & Research Centre Limited Financials
The company’s financial analysis is essential before applying for the Modern Diagnostic & Research Centre IPO. Look at the table to learn about Modern Diagnostic & Research Centre Limited’s financials.
| Year Ended | 30th June 2025 (in cr.) | 31st March 2025 (in cr.) | 31st March 2024 | 31st March 2023 |
| Assets | 77.86 | 64.57 | 49.49 | 36.54 |
| Revenue | 22.67 | 78.80 | 68.67 | 56.61 |
| Profit After Tax | 3.00 | 8.97 | 5.79 | -5.73 |
| EBITDA | 5.86 | 17.96 | 11.05 | -0.99 |
| Net Worth | 23.72 | 20.73 | 11.76 | 5.96 |
| Reserves and Surplus | 12.72 | 9.73 | 10.76 | 4.96 |
| Total Borrowings | 30.38 | 22.09 | 20.46 | 15.31 |
Explanation
Modern Diagnostic & Research Centre Limited’s revenue increased by 15% from ₹68.67 crores in March 2024 to ₹78.80 crores in March 2025. Moreover, the company’s PAT increased by 55% from ₹5.79 crores in March 2024 to ₹8.97 crores in March 2025.
Modern Diagnostic & Research Centre Limited IPO Promoter Holdings
Have a look at the table below to check the holdings of Modern Diagnostic & Research Centre Limited.
Mr Hitesh Kumar Singla, Mr Nikhil Singla, Mr Nitin Dixit, and Mr Anil Kumar Sharma.
| Shareholding Pre-Issue | 99.99% |
| Shareholding Post-Issue | 72.85% |
Note: The value will be calculated using Equity Dilution = Share Holding Pre Issue – Share Holding Post Issue.
Aim of the Modern Diagnostic & Research Centre IPO
The primary aim of the Modern Diagnostic & Research Centre IPO is to raise ₹50.20 crores. On the other hand, Modern Diagnostic & Research Centre has decided to utilise these funds in different ways.
- To fund capital expenditure for the purchase of medical equipment for the diagnostic centre and laboratories
- To Fund Working Capital Requirement
- To Repayment of certain outstanding borrowings availed by the Company
- To General Corporate Expenses
Should I Invest in the Modern Diagnostic & Research Centre IPO?
Explore the pros and cons of the Modern Diagnostic & Research Centre to know whether you should apply or avoid the issue. These pros and cons might help you understand the IPO’s efficiency in delivering profits over the coming decades.
Pros of the Modern Diagnostic & Research Centre IPO
- The company has an Experienced Promoter and Management Team.
- The company has a Comprehensive diagnostics provider delivering an all-in-one solution at cost-effective prices.
- The company has focused on quality and customer service
- The company has a Centralised information technology platform
Cons of the Modern Diagnostic & Research Centre IPO
- The company has a high business & operational risk
- The company has geographic & segment concentration
- The company has a historical financial weakness
- The company has regulatory & compliance risks
How to Apply for the Modern Diagnostic & Research Centre IPO?
Check the steps mentioned below to apply for Modern Diagnostic & Research Centre Ltd.
- Step 1: Conduct thorough research on the Modern Diagnostic & Research Centre IPO GMP, subscription status, issue size, lot size, and other details.
- Step 2: Open a demat account with Univest to access real-time insights on GMP and subscription status. You can also use your previous demat account by navigating to the IPO section.
- Step 3: Make a bid for 2 lot of 3,200 shares worth ₹2,88,000
- Step 4: You will receive a mandate request after making a bid. Approve the request to proceed further.
Note: You can apply for the Modern Diagnostic & Research Centre IPO across multiple demat accounts to increase your chances of allotment.
How to Check the Modern Diagnostic & Research Centre IPO Allotment Status?
You can check for the Modern Diagnostic & Research Centre IPO allotment in different ways. These include BSE and the registrar portal. Follow the steps below to check your allotment status online.
Check On BSE
- Visit the BSE Official Site
- Navigate to the IPO Allotment Section.
- Select Equity as the issue type.
- Choose the Modern Diagnostic & Research Centre IPO.
- Choose whether to proceed with the PAN number or the application number.
- Submit your details to get the allotment status online.
Check On the Registrar Portal
- Visit the registrar portal.
- Click on the allotment option.
- Fill in the required details.
- Click on the submit button to know your Modern Diagnostic & Research Centre IPO allotment status.
Let’s Wrap
Modern Diagnostic & Research Centre IPO is a bookbuilding issue of shares worth ₹36.89 crores. The shares of Modern Diagnostic & Research Centre Limited will be listed on BSE and SME on its tentative listing date of 7th January 2026. Researching the Modern Diagnostic & Research Centre IPO GMP and reviews is highly recommended to achieve your desired profitability. Brokers and investors have highlighted their pros and cons, so one must analyse them and decide accordingly.
Open a demat account on Univest now to initiate your investment journey!
FAQs on Modern Diagnostic & Research Centre IPO
How is the Modern Diagnostic & Research Centre IPO?
Ans. Currently, on 31st December 2025, the Modern Diagnostic & Research Centre GMP (Grey Market Premium) stands at ₹0. It indicates that the estimated listing price could be ₹90 per share. It is a bookbuilding IPO of ₹36.89 shares. The face value of each Modern Diagnostic & Research Centre share is ₹10 per share.
What is the Modern Diagnostic & Research Centre IPO price?
Ans. The Modern Diagnostic & Research Centre IPO issue price band is set at ₹85.00 to ₹90.00 per share.
Is the Modern Diagnostic & Research Centre IPO a good investment?
Ans. Modern Diagnostic & Research Centre Limited’s revenue increased by 15% from ₹68.67 crores in March 2024 to ₹78.80 crores in March 2025. Moreover, the company’s PAT increased by 55% from ₹5.79 crores in March 2024 to ₹8.97 crores in March 2025.
Who is the registrar of the Modern Diagnostic & Research Centre IPO?
Ans. MUFG Intime India Private Limited is the registrar for the Modern Diagnostic & Research Centre IPO, awaiting to manage the allotment process and initiate refunds. For any queries regarding the Modern Diagnostic & Research Centre allotment and refund, you can contact MUFG Intime India Private Limited at moderndiagnostic.smeipo@in.mpms.mufg.com or at +91-22-4918 6270.
What is the issue size of the Modern Diagnostic & Research Centre IPO?
Ans. Modern Diagnostic & Research Centre IPO is a bookbuilding IPO for ₹36.89 shares. Moreover, the IPO is set to open on 31st December 2025 and will be closed on 2nd January 2026.
Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Modern Diagnostic & Research Centre IPO, download the Modern Diagnostic & Research Centre IPO RHP and Modern Diagnostic & Research Centre IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.
Upcoming IPOs
| IPO Names | Expected Year of IPO |
| PhonePe IPO | 2025 |
| Bajaj Energy IPO | 2025 |
| OYO IPO | 2025 |
| NSDL IPO | 2025 |
| Flipkart IPO | 2025 |
| Zepto IPO | 2025 |
| Boat IPO | 2025 |
| Meesho IPO | 2025 |
| Jio IPO | 2026 |
| NSE IPO | 2025 |
Current & Previous IPOs
| Company | IPO Open | IPO Close | Type |
| Anthem Biosciences Limited | 14th July 2025 | 16th July 2025 | Mainboard |
| Spunweb Nonwoven Limited | 14th July 2025 | 16th July 2025 | SME |
| Smartworks Coworking Spaces Limited | 10th July 2025 | 14th July 2025 | Mainboard |
| CFF Fluid Control Limited | 9th July 2025 | 11th July 2025 | SME |
| GLEN Industries Limited | 8th July 2025 | 10th July 2025 | SME |
| Chemkart India Limited | 7th July 2025 | 9th July 2025 | SME |
| Travel Food Services Limited | 7th July 2025 | 9th July 2025 | Mainboard |
| Smarten Power Systems Limited | 7th July 2025 | 9th July 2025 | SME |
| Meta Infotech Limited | 4th July 2025 | 8th July 2025 | SME |
| Cryogenic OGS Limited | 3rd July 2025 | 7th July 2025 | SME |
| Happy Square Outsourcing Services Limited | 3rd July 2025 | 7th July 2025 | SME |
| Crizac Limited | 3rd July 2025 | 7th July 2025 | Mainboard |
| Silky Overseas Limited | 30th June 2025 | 2nd July 2025 | SME |
| Pushpa Jewellers Limited | 30th June 2025 | 2nd July 2025 | SME |
| Cedaar Textile Limited | 30th June 2025 | 2nd July 2025 | SME |
| Marc Loire Fashions Limited | 30th June 2025 | 2nd July 2025 | SME |
Read Our Articles on the Best Stocks
Tech Stocks in India to Invest in 2025 | Tech Sector Stocks
Best Battery Stocks in India to Invest in 2025 | Battery Sector Stocks
Best Shipping Stocks in India to Invest in 2025 | Shipping Sector Stocks
Paint Stocks in India to Invest in 2025 | Paint Sector Stocks
Paper Stocks in India to Invest in 2025 | Paper Sector Stocks
Best Semiconductor Stocks in India 2025
Best Large Cap Stocks in India 2025
Best Cement Stocks To Invest In India
Also Explore
Univest Screeners
Explore Webstories on Univest
Best Time To Buy Dividend Stocks
How RBI Policies Affect Dividend Stocks
Can Dividend Stocks Beat Inflation
What Is The Dividend Aristocrat List
